SEP 11, 2026 · PHASE 1/2 TRIAL
SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
ClinicalTrials.gov
This is a Phase 1/2 single-arm trial still recruiting with no posted results; early-phase design and lack of comparative data limit evidential strength.
Reported
Planned enrollment31
Primary outcome measureIntracranial Progression Free Survival (PFS…
Study phasePhase 1, Phase 2